The taintedblood Timeline - what really happened...
"To no one will we sell, to no one deny or delay, right or justice."
Magna Carta - 15th June, 1215
No of entries selected: 2 of 711
SNBTS - Early Knowledge of Creutzfeldt-Jakob Disease (CJD)
In the minutes of the first SNBTS Factor VIII Study Group, it is clear that physicians have knowledge as early as 1982 of the viral risk of the Creutzfeldt-Jakob agent (CJD) in blood products. It should be noted that the agent referred to here is not the variant form (vCJD), which was not classified until March / April 1996.
Classical CJD or Sporadic CJD is the most common form of Human TSE.
CJD was first described in 1921 by two German neurologists, Hans Gerhard Creutzfeldt and Alfons Maria Jakob. The disease is not related to food consumption. The neurologists do, however, describe a case of progressive fatal dementia in a female patient; accompanied by multiple neurological abnormalities.
Variant Creutzfeldt-Jakob Disease (vCJD) - First Documented
A new disease, vCJD, is first described and documented in April 1996. The first cases of Variant CJD (vCJD) actually appeared in 1995, but it was not until 1996 that the new variant of CJD was recognised.
Timeline Copyright ©2006 Andrew March & Haydn Lewis
All rights reserved